Emílio Pizzichini

14.8k total citations · 5 hit papers
129 papers, 10.7k citations indexed

About

Emílio Pizzichini is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Immunology and Allergy. According to data from OpenAlex, Emílio Pizzichini has authored 129 papers receiving a total of 10.7k indexed citations (citations by other indexed papers that have themselves been cited), including 97 papers in Pulmonary and Respiratory Medicine, 97 papers in Physiology and 10 papers in Immunology and Allergy. Recurrent topics in Emílio Pizzichini's work include Asthma and respiratory diseases (93 papers), Respiratory and Cough-Related Research (54 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (49 papers). Emílio Pizzichini is often cited by papers focused on Asthma and respiratory diseases (93 papers), Respiratory and Cough-Related Research (54 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (49 papers). Emílio Pizzichini collaborates with scholars based in Brazil, United States and Canada. Emílio Pizzichini's co-authors include Márcia Margaret Menezes Pizzichini, Ann Efthimiadis, Jerry Dolovich, Paul M. O’Byrne, F.E. Hargreave, Frederick E. Hargreave, Eric D. Bateman, Peter G. Gibson, Suzanne S. Hurd and Jeffrey M. Drazen and has published in prestigious journals such as New England Journal of Medicine, SHILAP Revista de lepidopterología and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

Emílio Pizzichini

124 papers receiving 10.4k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Global strategy for asthma management and prevention: GINA executive summary

2007 2.4k citations Eric D. Bateman, Suzanne S. Hurd et al. European Respiratory Journal profile →
Mepolizumab for Prednisone-Dependent Asthma with Sputum Eosinophilia

2009 977 citations Parameswaran Nair, Márcia Margaret Menezes Pizzichini et al. profile →
Indices of Airway Inflammation in Induced Sputum: Reproducibility and Validity of Cell and Fluid-Phase Measurements

1996 803 citations Emílio Pizzichini, Márcia Margaret Menezes Pizzichini et al. American Journal of Respiratory and Critical Care Medicine profile →
A summary of the new GINA strategy: a roadmap to asthma control

2015 550 citations Eric D. Bateman, Louis‐Philippe Boulet et al. European Respiratory Journal profile →
Benralizumab, an anti-interleukin 5 receptor α monoclonal antibody, versus placebo for uncontrolled eosinophilic asthma: a phase 2b randomised dose-ranging study

2014 362 citations Sally E. Wenzel, Eugene R. Bleecker et al. profile →

Peers

Emílio Pizzichini

PHYSI

PRM

IMMUN

SURGE

Elisabeth H. Bel Netherlands

Neil Barnes United Kingdom

Vibeke Backer Denmark

Richard Leigh Canada

Leonard B. Bacharier United States

E. Rand Sutherland United States

Robert C. Strunk United States

Søren Pedersen Denmark

Alfredo Chetta Italy

Bradley E. Chipps United States

Elisabeth H. Bel Netherlands

Emílio Pizzichini

9.9k ×1.1

PHYSI

8.2k ×1.1

PRM

1.9k ×1.2

1.6k ×1.2

IMMUN

1.2k ×1.3

SURGE

Citations per year, relative to Emílio Pizzichini Emílio Pizzichini (= 1×) peers Elisabeth H. Bel

Countries citing papers authored by Emílio Pizzichini

Since Specialization

Citations

This map shows the geographic impact of Emílio Pizzichini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emílio Pizzichini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emílio Pizzichini more than expected).

Fields of papers citing papers by Emílio Pizzichini

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emílio Pizzichini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emílio Pizzichini. The network helps show where Emílio Pizzichini may publish in the future.

Co-authorship network of co-authors of Emílio Pizzichini

This figure shows the co-authorship network connecting the top 25 collaborators of Emílio Pizzichini. A scholar is included among the top collaborators of Emílio Pizzichini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emílio Pizzichini. Emílio Pizzichini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Heaney, Liam G., Désirée Larenas‐Linnemann, Riyad Al‐Lehebi, et al.. (2025). Regional challenges to optimize the management of patients with severe asthma type 2 inflammation: a Delphi consensus in seven countries. Journal of Asthma. 62(6). 929–944. 1 indexed citations

Pizzichini, Emílio, et al.. (2024). Run-in periods and treatment outcomes in asthma trials: A narrative review. Contemporary Clinical Trials Communications. 42. 101382–101382. 1 indexed citations

Boulet, Louis‐Philippe, Carl Abbott, Guy Brusselle, et al.. (2024). Baseline Characteristics and ICS/LAMA/LABA Response in Asthma: Analyses From the CAPTAIN Study. The Journal of Allergy and Clinical Immunology In Practice. 12(5). 1244–1253.e8. 2 indexed citations

Oppenheimer, John, Huib A.M. Kerstjens, Louis‐Philippe Boulet, et al.. (2024). Characterization of Moderate and Severe Asthma Exacerbations in the CAPTAIN Study. The Journal of Allergy and Clinical Immunology In Practice. 12(9). 2372–2380.e5. 1 indexed citations

Pizzichini, Márcia Margaret Menezes, Mirella Dias, Darlan Laurício Matte, et al.. (2019). Body mass index, asthma, and respiratory symptoms: a population-based study. Jornal Brasileiro de Pneumologia. 46(1). e20190006–e20190006. 10 indexed citations

Fröde, Tânia Sílvia, et al.. (2019). Prevalence of smoking and reasons for continuing to smoke: a population-based study. Jornal Brasileiro de Pneumologia. 45(4). e20170080–e20170080. 16 indexed citations

Matte, Darlan Laurício, et al.. (2019). Translation and cultural adaptation of the King’s Brief Interstitial Lung Disease health status questionnaire for use in Brazil. Jornal Brasileiro de Pneumologia. 45(5). e20180194–e20180194. 3 indexed citations

Pizzichini, Emílio, et al.. (2018). Rhinosinusitis symptoms, smoking and COPD: Prevalence and associations. Clinical Otolaryngology. 43(6). 1560–1565. 10 indexed citations

Pizzichini, Márcia Margaret Menezes, Huib A.M. Kerstjens, & Emílio Pizzichini. (2015). Current role of anticholinergic drugs in the treatment of asthma: key messages for clinical practice. Polskie Archiwum Medycyny Wewnętrznej. 125(11). 859–866. 3 indexed citations

10.

Dahl, Ronald, Eric D. Bateman, Thomas B. Casale, et al.. (2014). Once-daily tiotropium Respimat (R) as add-on to at least medium- to high-dose ICS, with or without LABA, improves lung function in patients with symptomatic asthma, independent of allergic status. Allergy. 69. 515–515. 2 indexed citations

11.

Kerstjens, Huib A.M., Eugene R. Bleecker, Eli O. Meltzer, et al.. (2013). Tiotropium as add-on therapy to inhaled corticosteroids for patients with symptomatic asthma: Lung function and safety. European Respiratory Journal. 42(Suppl 57). 4629–4629. 4 indexed citations

12.

Koch, Andrea, Pierluigi Paggiaro, Alan Hamilton, et al.. (2013). Symptomatic benefit of olodaterol QD delivered via Respimat® vs placebo and formoterol BID in patients with COPD: Combined analysis from two 48-week studies. European Respiratory Journal. 42(Suppl 57). P763–P763. 7 indexed citations

13.

Chakir, Jamila, Lionel Loubaki, Michel Laviolette, et al.. (2009). Monitoring sputum eosinophils in mucosal inflammation and remodelling: a pilot study. European Respiratory Journal. 35(1). 48–53. 16 indexed citations

14.

Pizzichini, Emílio, et al.. (2007). Diretrizes brasileiras para tratamento das pneumonias adquiridas no hospital e das associadas à ventilação mecânica - 2007. Jornal Brasileiro de Pneumologia. 33(suppl 1). s1–s30. 25 indexed citations

15.

Bateman, Eric D., Suzanne S. Hurd, Peter J. Barnes, et al.. (2007). Global strategy for asthma management and prevention: GINA executive summary. European Respiratory Journal. 31(1). 143–178. 2390 indexed citations breakdown →

16.

Leigh, Richard, Márcia Margaret Menezes Pizzichini, Michael J. Morris, et al.. (2006). Stable COPD: predicting benefit from high-dose inhaled corticosteroid treatment. European Respiratory Journal. 27(5). 964–971. 210 indexed citations

17.

Pizzichini, Emílio, Márcia Margaret Menezes Pizzichini, Peter G. Gibson, et al.. (1998). Sputum Eosinophilia Predicts Benefit from Prednisone in Smokers with Chronic Obstructive Bronchitis. American Journal of Respiratory and Critical Care Medicine. 158(5). 1511–1517. 284 indexed citations

18.

Pizzichini, Emílio, et al.. (1998). Potential Masking Effects of Salmeterol on Airway Inflammation in Asthma. American Journal of Respiratory and Critical Care Medicine. 158(3). 924–930. 222 indexed citations

19.

Pizzichini, Márcia Margaret Menezes, Emílio Pizzichini, Ann Efthimiadis, et al.. (1998). Asthma and Natural Colds: Inflammatory Indices in Induced Sputum: A Feasibility Study. American Journal of Respiratory and Critical Care Medicine. 158(4). 1178–1184. 159 indexed citations

20.

Pizzichini, Emílio, Márcia Margaret Menezes Pizzichini, Ann Efthimiadis, et al.. (1996). Indices of Airway Inflammation in Induced Sputum: Reproducibility and Validity of Cell and Fluid-Phase Measurements. American Journal of Respiratory and Critical Care Medicine. 154(2). 308–317. 803 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact